Regression of fibrous dysplasia in response to denosumab therapy: A report of two cases

We present two patients with fibrous dysplasia who showed a decrease in lesional size and activity after denosumab therapy. Both patients also experienced a reduction in pain and bone turnover markers, which had not been accomplished during previous bisphosphonate therapy. These cases highlight the...

Full description

Bibliographic Details
Main Authors: Maartje E. Meier, Wouter van der Bruggen, Michiel A.J. van de Sande, Natasha M. Appelman-Dijkstra
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Bone Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352187221003132